Covid-19 pandemic now resurgent across the globe, it’s a comfort to know that there are several promising vaccine candidates in speedy development.
Their success is crucial in fighting the virus and charting a path back to normal. It's important, though, that we are able to see rigorous, clean and transparent trial data, to help gain trust in any vaccine and know that proper protocols are in place.
Unfortunately, one of the leading vaccine candidates – from AstraZeneca Plc, working with the University of Oxford — is having a problem in this area.Astra and Oxford released interim data last week from their Covid-19 vaccine trials in the UK and Brazil, becoming the third developers after Moderna Inc.